Colorectal cancer (CRC) remains the second leading cause of cancer death in the U.S.—even as incidence and mortality have declined.…
Browsing: Clinical Updates
For patients with IBD, monitoring the disease often means enduring repeat colonoscopies—uncomfortable, invasive, and time-consuming. But Pfizer is helping change…
What if a workout routine could rival traditional cancer treatments? At the ASCO Annual Meeting, a groundbreaking trial revealed that…
In a landmark update, the NCCN has added two noninvasive tests—ColoSense and Shield—to its official colorectal cancer screening guidelines. ✅…
A rising tide of evidence suggests that complementary and mind-body therapies may be quietly transforming how we treat gastrointestinal (GI)…
Guardant Health just unveiled nearly a dozen new capabilities for its Guardant360® Liquid blood test—turning a routine draw into a…
Screening for colorectal cancer just got radically easier. New Day Diagnostics has launched ColoHealth™, a first-of-its-kind blood test available direct-to-consumer—no…
At DDW 2025, researchers unveiled a blood-based risk score that can predict the onset of Crohn’s disease (CD) up to…
In what could signal a paradigm shift in GI bleeding management, South Korea-based Nextbiomedical has published results in GUT showing…
Imagine diagnosing upper GI bleeding without an endoscopy. A new ingestible capsule, PillSense, is doing just that—providing real-time detection of…